Leading the Way in Life Science Technologies

GEN Exclusives

More »

New Products

More »
May 15, 2012 (Vol. 32 , No. 10)

qPCR Primer Reagents

Click Image To Enlarge +

Swift Biosciences

myT™ Primer reagents are designed to detect key cancer mutations and aid with qPCR assays. The reagents have structural and thermodynamic properties that enable sensitive mismatch discrimination. myT BRAF, the first product in the myT Primer line, can detect 1% mutant BRAF V600E/K present in a background of 103 wild-type genomic DNA copies with no breakthrough amplification from wild type. myT BRAF can perform with either FFPE or fresh frozen samples. Each myT BRAF package includes enough reagents to assess up to 28 samples plus a positive and a negative control.

Related To This Company

Related content